Goldsmith Bruce A

SVP, Corporate Development at ALLOS THERAPEUTICS INC · on record since Nov 17, 2011
Director at Passage BIO, Inc. · on record since Feb 27, 2020
CEO and President at Passage BIO, Inc. · on record since Feb 27, 2020

Insider trading activity of Goldsmith Bruce A

Transactions on record: 18; since Oct 22, 2010

Open-market buys: 3; $77.5K

Open-market sells: 8; $45.7K

Companies traded: 2; last filing Jun 1, 2022

Figures computed from official regulatory filings — .

Companies where Goldsmith Bruce A has traded

Passage BIO, Inc.6 tx · $77.5K · Jun 1, 2022
ALLOS THERAPEUTICS INC12 tx · $677.1K · Sep 5, 2012

Track record of Goldsmith Bruce A

Insufficient history for a statistical track record (fewer than 5 open-market buys).

Transaction history of Goldsmith Bruce A

Co-insiders of Goldsmith Bruce A

14159 capital (GP), LLCALLOS THERAPEUTICS INC
ABRAHAM DONALD JALLOS THERAPEUTICS INC
Baker Biotech Capital (GP), LLCALLOS THERAPEUTICS INC
Baker Biotech Capital III (GP), LLCALLOS THERAPEUTICS INC
Baker Bros. Capital (GP), LLCALLOS THERAPEUTICS INC
BAKER FELIXALLOS THERAPEUTICS INC
BAKER JULIANALLOS THERAPEUTICS INC
Baker / Tisch Capital (GP), LLCALLOS THERAPEUTICS INC
BENNETT BRUCE K JRALLOS THERAPEUTICS INC
BERNS PAUL LALLOS THERAPEUTICS INC
Borthwick KathleenPassage BIO, Inc.
Burkavage BrianPassage BIO, Inc.
CAGNONI PABLO JALLOS THERAPEUTICS INC
Cale Edgar B.Passage BIO, Inc.
CARUSO JAMES VALLOS THERAPEUTICS INC
CASEY MICHAEL DALLOS THERAPEUTICS INC
Chou WilliamPassage BIO, Inc.
Clark David CALLOS THERAPEUTICS INC
Countouriotis AthenaPassage BIO, Inc.
DELONG DAVID AALLOS THERAPEUTICS INC
DeSilva Nishan MALLOS THERAPEUTICS INC
DURUS CAPITAL MANAGEMENTALLOS THERAPEUTICS INC

This page republishes public regulatory disclosures.

Company	Filed	Type	Qty	Price	Value · USD	Signals	Src
Passage BIO, Inc.Listing on record	Jun 1, 2022	AwardD (derivative)	100,000	0.00 USD	n/a (Non-cash transaction: the filing states a price of zero (award, gift, exercise))		SEC
Passage BIO, Inc.Listing on record	Mar 23, 2022	Buy	10,000	3.15 USD	$31.5K	conv 85Cluster	SEC
Passage BIO, Inc.Listing on record	Feb 14, 2022	AwardD (derivative)	400,000	0.00 USD	n/a (Non-cash transaction: the filing states a price of zero (award, gift, exercise))		SEC
Passage BIO, Inc.Listing on record	May 21, 2021	Buy	2,000	13.12 USD	$26.2K	conv 78First in 12mo	SEC
Passage BIO, Inc.Listing on record	Feb 18, 2021	AwardD (derivative)	262,000	0.00 USD	n/a (Non-cash transaction: the filing states a price of zero (award, gift, exercise))		SEC
Passage BIO, Inc.Listing on record	Mar 3, 2020	Buy	1,100	18.00 USD	$19.8K	conv 96ClusterFirst in 12mo	SEC
ALLOS THERAPEUTICS INCListing unverified	Sep 5, 2012	Other	-346,933	1.82 USD	$631.4K		SEC
ALLOS THERAPEUTICS INCListing unverified	Mar 1, 2012	Sell	-4,505	1.52 USD	$6.8K		SEC
ALLOS THERAPEUTICS INCListing unverified	Mar 1, 2012	Sell	-4,473	1.50 USD	$6.7K		SEC
ALLOS THERAPEUTICS INCListing unverified	Mar 1, 2012	Award	179,727	0.00 USD	n/a (Non-cash transaction: the filing states a price of zero (award, gift, exercise))		SEC
ALLOS THERAPEUTICS INCListing unverified	Feb 27, 2012	Sell	-575	1.54 USD	$885.5		SEC
ALLOS THERAPEUTICS INCListing unverified	Feb 27, 2012	Sell	-2,500	1.58 USD	$4K		SEC
ALLOS THERAPEUTICS INCListing unverified	Nov 17, 2011	Sell	-300	1.43 USD	$429		SEC
ALLOS THERAPEUTICS INCListing unverified	Nov 17, 2011	Sell	-12,465	1.44 USD	$17.9K		SEC
ALLOS THERAPEUTICS INCListing unverified	Mar 2, 2011	Award	67,298	0.00 USD	n/a (Non-cash transaction: the filing states a price of zero (award, gift, exercise))		SEC
ALLOS THERAPEUTICS INCListing unverified	Feb 25, 2011	Sell	-2,250	3.25 USD	$7.3K		SEC
ALLOS THERAPEUTICS INCListing unverified	Feb 25, 2011	Sell	-507	3.12 USD	$1.6K		SEC
ALLOS THERAPEUTICS INCListing unverified	Oct 22, 2010	Award	100,671	0.00 USD	n/a (Non-cash transaction: the filing states a price of zero (award, gift, exercise))		SEC

Company	Filed	Type	Qty	Price	Value · USD	Signals	Src
Passage BIO, Inc.Listing on record	Jun 1, 2022	AwardD (derivative)	100,000	0.00 USD	n/a (Non-cash transaction: the filing states a price of zero (award, gift, exercise))		SEC
Passage BIO, Inc.Listing on record	Mar 23, 2022	Buy	10,000	3.15 USD	$31.5K	conv 85Cluster	SEC
Passage BIO, Inc.Listing on record	Feb 14, 2022	AwardD (derivative)	400,000	0.00 USD	n/a (Non-cash transaction: the filing states a price of zero (award, gift, exercise))		SEC
Passage BIO, Inc.Listing on record	May 21, 2021	Buy	2,000	13.12 USD	$26.2K	conv 78First in 12mo	SEC
Passage BIO, Inc.Listing on record	Feb 18, 2021	AwardD (derivative)	262,000	0.00 USD	n/a (Non-cash transaction: the filing states a price of zero (award, gift, exercise))		SEC
Passage BIO, Inc.Listing on record	Mar 3, 2020	Buy	1,100	18.00 USD	$19.8K	conv 96ClusterFirst in 12mo	SEC
ALLOS THERAPEUTICS INCListing unverified	Sep 5, 2012	Other	-346,933	1.82 USD	$631.4K		SEC
ALLOS THERAPEUTICS INCListing unverified	Mar 1, 2012	Sell	-4,505	1.52 USD	$6.8K		SEC
ALLOS THERAPEUTICS INCListing unverified	Mar 1, 2012	Sell	-4,473	1.50 USD	$6.7K		SEC
ALLOS THERAPEUTICS INCListing unverified	Mar 1, 2012	Award	179,727	0.00 USD	n/a (Non-cash transaction: the filing states a price of zero (award, gift, exercise))		SEC
ALLOS THERAPEUTICS INCListing unverified	Feb 27, 2012	Sell	-575	1.54 USD	$885.5		SEC
ALLOS THERAPEUTICS INCListing unverified	Feb 27, 2012	Sell	-2,500	1.58 USD	$4K		SEC
ALLOS THERAPEUTICS INCListing unverified	Nov 17, 2011	Sell	-300	1.43 USD	$429		SEC
ALLOS THERAPEUTICS INCListing unverified	Nov 17, 2011	Sell	-12,465	1.44 USD	$17.9K		SEC
ALLOS THERAPEUTICS INCListing unverified	Mar 2, 2011	Award	67,298	0.00 USD	n/a (Non-cash transaction: the filing states a price of zero (award, gift, exercise))		SEC
ALLOS THERAPEUTICS INCListing unverified	Feb 25, 2011	Sell	-2,250	3.25 USD	$7.3K		SEC
ALLOS THERAPEUTICS INCListing unverified	Feb 25, 2011	Sell	-507	3.12 USD	$1.6K		SEC
ALLOS THERAPEUTICS INCListing unverified	Oct 22, 2010	Award	100,671	0.00 USD	n/a (Non-cash transaction: the filing states a price of zero (award, gift, exercise))		SEC